Thorac Cardiovasc Surg 2006; 54(7): 477-483
DOI: 10.1055/s-2006-923978
Original Thoracic

© Georg Thieme Verlag KG Stuttgart · New York

Beneficial Effects of Supplemental Nitric Oxide Donor Given during Reperfusion Period in Reperfusion-Induced Lung Injury

H. Esme1 , H. Fidan2 , O. Solak1 , F. H. Dilek3 , R. Demirel4 , M. Unlu5
  • 1Department of Thoracic Surgery, Kocatepe University School of Medicine, Afyon, Turkey
  • 2Department of Anesthesia, Kocatepe University School of Medicine, Afyon, Turkey
  • 3Department of Pathology, Kocatepe University School of Medicine, Afyon, Turkey
  • 4Department of Public Health, Kocatepe University School of Medicine, Afyon, Turkey
  • 5Department of Chest Diseases, Kocatepe University School of Medicine, Afyon, Turkey
Further Information

Publication History

Received September 15, 2005

Publication Date:
06 November 2006 (online)

Abstract

Background: Reperfusion injury is a perplexing cause of early graft failure after lung transplantation and today we know that reperfusion may be more harmful to tissues than the preceding ischemia. We hypothesized that administration of the nitric oxide donor nitroglycerin (NTG) during flush perfusion and reperfusion periods would ameliorate reperfusion-induced lung injury. Methods: Using an in situ normothermic ischemic lung rabbit model, three groups were studied (n = 7/group): (1) NTG given during flush perfusion (ischemia group); (2) NTG given in the flush perfusion and the reperfusion period (reperfusion group); and (3) no NTG (control group). All groups were flushed with low potassium dextran glucose solution. Blood gas analysis, tissue nitrite (nitric oxide metabolite) level analysis, bronchoalveolar lavage (BAL) fluid examination and morphological examinations were performed. Results: Compared with the ischemia group, the reperfusion group had significantly improved arterial oxygenation (318 ± 31.4 mmHg vs. 180 ± 14.7 mmHg, p < 0.05), decreased BAL fluid neutrophil percentage (21 ± 1.9 % vs. 30 ± 5.6 %, p < 0.05), increased tissue nitrite level (32.55 ± 4.12 nmol/g vs. 27.81 ± 1.05 nmol/g, p < 0.05), and decreased tissue histopathological lesion scores (0.42 ± 0.53 vs. 1.14 ± 0.37, p < 0.05). Conclusions: This study suggests that nitric oxide donors supplemented during flush perfusion and reperfusion have more beneficial effects on lung functions against reperfusion injury than any other treatment modalities during in situ normothermic ischemic lung model.

References

  • 1 Haydock D A, Trulock E P, Kaiser L R, Knight S R, Pasque M K, Cooper J D. Management of dysfunction in the transplanted lung: experience with 7 clinical cases. Washington University Lung Transplant Group.  Ann Thorac Surg. 1992;  53 635-641
  • 2 Ware L B, Golden J A, Finkbeiner W E, Matthay M A. Alveolar epithelial fluid transportcapacity in reperfusion lung injury after lung transplantation.  Am J Respir Crit Care Med. 1999;  159 980-988
  • 3 McCurry K R, Keenan R J. Controlling perioperative morbidity and mortality after lung transplantation for pulmonary hypertension.  Semin Thorac Cardiovasc Surg. 1998;  10 139-143
  • 4 Lu Y T, Liu S F, Mitchell J A, Malik A B, Hellewell P G, Evans T W. The role of endogenous nitric oxide in modulating ischemia-reperfusion injury in the isolated, blood-perfused rat lung.  Am J Respir Crit Care Med. 1998;  157 273-279
  • 5 Furchgott R F, Zawadzki J V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine.  Nature. 1980;  288 373-376
  • 6 Pillai R, Bando K, Schueler S, Zebly M, Reitz B A, Baumgartner W A. Leukocyte depletion results in excellent heart-lung function after 12 hours of storage.  Ann Thorac Surg. 1990;  50 211-214
  • 7 Naka Y, Chowdhury N C, Liao H, Roy D K, Oz M C, Michler R E. et al . Enhanced preservation of orthotopically transplanted rat lungs by nitroglycerin but not hydralazine: requirement for graft vascular homeostasis beyond harvest vasodilation.  Circ Res. 1995;  76 900-906
  • 8 Kayano K, Toda K, Naka Y, Okada K, Oz M C, Pinsky D J. Superior protection in orthotopic rat lung transplantation with cyclic adenosine monophosphate and nitroglycerin-containing preservation solution.  J Thorac Cardiovasc Surg. 1999;  118 135-144
  • 9 Pinsky D J. The vascular biology of heart and lung preservation for transplantation.  Thromb Haemost. 1995;  74 58-65
  • 10 Yamashita M, Schmid R A, Ando K, Cooper J D, Patterson G A. Nitroprusside ameliorates lung allograft reperfusion injury.  Ann Thorac Surg. 1996;  62 791-797
  • 11 Granger D L, Taintor R R, Bookvar K S, Hibbs J B. Measurement of nitrite and nitrate in biological samples using nitrate reductase and Greis reaction.  Methods Enzymol. 1996;  268 142-151
  • 12 Rotta A T, Gunnarsson B, Hernan L J, Fuhrman B P, Steinhorn D M. Partial liquid ventilation influences pulmonary histopathology in an animal model of acute lung injury.  J Crit Care. 1999;  14 84-92
  • 13 Kilgore K S, Lucchesi B R. Reperfusion injury after myocardial infarction: the role of free radicals and the inflammatory response.  Clin Biochem. 1993;  26 359-370
  • 14 McQuaid K E, Smyth E M, Kenan A K. Evidence for modulation of hydrogen peroxide-induced endothelial barrier dysfunction by nitric oxide in vitro.  Eur J Pharmacol. 1996;  307 233-241
  • 15 Ohlin H, Pavlidis N, Ohlin A K. Effect of intravenous nitroglycerin on lipid peroxidation after thrombolytic therapy for acute myocardial infarction.  Am J Cardiol. 1998;  82 1463-1467
  • 16 Simonson M S, Dunn M J. Endothelin: pathways of transmembrane signaling.  Hypertension. 1990;  15 5-12
  • 17 Kourembas S, McQuillan L P, Leung G K, Faller D V. Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia.  J Clin Invest. 1993;  92 99-104
  • 18 Ignarro L J, Ross G, Tillisch J. Pharmacology of endothelium-derived nitric oxide and nitrovasodilators.  West J Med. 1991;  154 51-62
  • 19 Husain M, Adrie C, Ichinose F, Kavosi M, Zapol W M. Exhaled nitric oxide as a marker for organic nitrate tolerance.  Circul. 1994;  89 2498-2502
  • 20 Minamoto K, Pinsky D J, Fujita T, Naka Y. Timing of nitric oxide donor supplementation determines endothelin-1 regulation and quality of lung preservation for transplantation.  Am J Respir Cell Mol Biol. 2002;  26 14-21
  • 21 Pinsky D J, Oz M C, Koga S, Taha Z, Broekman M J, Marcus A J. et al . Cardiac preservation is enhanced in a heterotopic rat transplant model by supplementing the nitric oxide pathway.  J Clin Invest. 1994;  93 2291-2297
  • 22 Hogg N, Darley Usmar V M, Wilson M T, Moncada S. Production of hydroxyl radicals from the simultaneous generation of superoxide and nitric oxide.  Biochem J. 1992;  281 419-424
  • 23 Kawashima M, Bando T, Nakamura T, Isowa N, Lio M, Toyokuni S. et al . Cytoprotective effects of nitroglycerin in ischemia-reperfusion-induced lung injury.  Am J Respir Crit Care Med. 2000;  161 935-943
  • 24 Zhang J M, Orihashi K, Sueda T, Matsuura Y. Cardioprotective effects of FK409, a nitric oxide donor, after isolated rat heart preservation for 16 hours.  Ann Thorac Surg. 2000;  70 1601-1606
  • 25 Welbourn C R, Goldman G, Paterson I S, Valeri C R, Shepro D, Hechtman H B. Pathophysiology of ischemia reperfusion injury: central role of neutrophil.  Br J Surg. 1991;  78 651-655
  • 26 Marczin N, Riedel B, Royston D, Yacoub M. Intravenous nitrate vasodilators and exhaled nitric oxide.  Lancet. 1997;  349 1742
  • 27 Bhabra M S, Hopkinson D N, Shaw T E, Hooper T L. Attenuation of lung graft reperfusion injury by a nitric oxide donor.  J Thorac Cardiovasc Surg. 1997;  113 327-333
  • 28 Farber J L. Membrane injury and calcium homeostasis in the pathogenesis of coagulative necrosis.  Lab Invest. 1982;  47 114
  • 29 Tauber A I, Babior B M. Neutrophil oxygen reduction: the enzymes and the products.  Adv Free Radic Biol Med. 1985;  1 265
  • 30 Pillai R, Bando K, Schueler S, Zebly M, Reitz B A, Baumgartner W A. Leukocyte depletion results in excellent heart-lung function after 12 hours of storage.  Ann Thorac Surg. 1990;  50 211-214
  • 31 Mercer R R, Russell M L, Roggli V L, Crapo J D. Cell number and distribution in human and rat airways.  Am J Respir Cell Mol Biol. 1994;  10 613-624
  • 32 Waldow T, Alexiou K, Witt W, Wagner F M, Gulielmos V, Matschke K, Knaut M. Attenuation of reperfusion-induced systemic inflammation by preconditioning with nitric oxide in an in situ porcine model of normothermic lung ischemia.  Chest. 2004;  125 2253-2259
  • 33 Yoshida S, Sekine Y, Saitoh Y, Yasufuku K, Iwata T, Fujisawa T. Surgical technique of experimental lung transplantation in rabbits.  Ann Thorac Cardiovasc Surg. 2005;  11 7-11
  • 34 Piotrowski J A, Splittgerber F H, Donovan T J, Ratjen F, Zerkowski H R. Single-lung transplantation in a patient with cystic fibrosis and an asymmetric thorax.  Ann Thorac Surg. 1997;  64 1456-1458

MD Hidir Esme

Afyon Kocatepe University, Faculty of Medicine
Department of Thoracic Surgery

03200 Afyon

Turkey

Phone: + 90 53 36 47 17 29

Fax: + 90 27 22 17 20 29

Email: hesme@aku.edu.tr